REFERENCES
1. Breuer J, Schwab N, Schneider-Hohendorf T, et al. Ultraviolet B light
attenuates the systemic immune response in central nervous system
autoimmunity. Ann Neurol. 2014;75(5):739-758.2. Hayashi T, Sasaki
N, Yamashita T, et al. Ultraviolet B Exposure Inhibits Angiotensin
II-Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding
CD4(+)Foxp3(+) Regulatory T Cells. J Am Heart Assoc. 2017;6(9).3.
Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell
density determines whether contact hypersensitivity or unresponsiveness
follows skin painting with DNFB. J Immunol. 1980;124(1):445-453.4. Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ,
Streilein JW. Analysis of the mechanism of unresponsiveness produced by
haptens painted on skin exposed to low dose ultraviolet radiation.J Exp Med. 1983;158(3):781-794.5. Ullrich SE, Magee M. Specific
suppression of allograft rejection after treatment of recipient mice
with ultraviolet radiation and allogeneic spleen cells.Transplantation. 1988;46(1):115-119.6. Hori T, Kuribayashi K,
Uemoto S, et al. Alloantigen-specific prolongation of allograft survival
in recipient mice treated by alloantigen immunization following
ultraviolet-B irradiation. Transpl Immunol. 2008;19(1):45-54.7.
Yamazaki S, Odanaka M, Nishioka A, et al. Ultraviolet B-Induced
Maturation of CD11b-Type Langerin(-) Dendritic Cells Controls the
Expansion of Foxp3(+) Regulatory T Cells in the Skin. J Immunol. 2018;200(1):119-129.8. Sasaki N, Yamashita T, Kasahara K, et al. UVB
Exposure Prevents Atherosclerosis by Regulating Immunoinflammatory
Responses. Arterioscler Thromb Vasc Biol. 2017;37(1):66-74.9.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune
tolerance. Cell. 2008;133(5):775-787.10. Rudensky AY. Regulatory
T cells and Foxp3. Immunol Rev. 2011;241(1):260-268.11.
Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory
signals control the homeostasis and function of regulatory T cells.Immunol Rev. 2009;229(1):41-66.12. Abbas AK, Benoist C, Bluestone
JA, et al. Regulatory T cells: recommendations to simplify the
nomenclature. Nat Immunol. 2013;14(4):307-308.13. Weiss JM,
Bilate AM, Gobert M, et al. Neuropilin 1 is expressed on thymus-derived
natural regulatory T cells, but not mucosa-generated induced Foxp3+ T
reg cells. J Exp Med. 2012;209(10):1723-1742, S1721.14. Benson
MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid
mediates enhanced T reg cell growth, differentiation, and gut homing in
the face of high levels of co-stimulation. J Exp Med. 2007;204(8):1765-1774.15. Haribhai D, Williams JB, Jia S, et al. A
requisite role for induced regulatory T cells in tolerance based on
expanding antigen receptor diversity. Immunity. 2011;35(1):109-122.16. Josefowicz SZ, Niec RE, Kim HY, et al.
Extrathymically generated regulatory T cells control mucosal TH2
inflammation. Nature. 2012;482(7385):395-399.17. Kim BS, Kim IK,
Park YJ, et al. Conversion of Th2 memory cells into Foxp3+ regulatory T
cells suppressing Th2-mediated allergic asthma. Proc Natl Acad Sci
U S A. 2010;107(19):8742-8747.18. Amarnath S, Mangus CW, Wang JC, et
al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.Sci Transl Med. 2011;3(111):111ra120.19. Silpa-Archa N,
Weerasubpong P, Junsuwan N, Yothachai P, Supapueng O, Wongpraparut C.
Treatment outcome and persistence of repigmentation from narrow-band
ultraviolet B phototherapy in vitiligo. J Dermatolog Treat. 2019;30(7):691-696.20. Ye J, Huang H, Luo G, et al. NB-UVB irradiation
attenuates inflammatory response in psoriasis. Dermatol Ther. 2020;33(4):e13626.21. Tintle S, Shemer A, Suarez-Farinas M, et al.
Reversal of atopic dermatitis with narrow-band UVB phototherapy and
biomarkers for therapeutic response. J Allergy Clin Immunol. 2011;128(3):583-593 e581-584.22. Kemeny L, Varga E, Novak Z. Advances in
phototherapy for psoriasis and atopic dermatitis. Expert Rev Clin
Immunol. 2019;15(11):1205-1214.23. Bernard JJ, Gallo RL, Krutmann J.
Photoimmunology: how ultraviolet radiation affects the immune system.Nat Rev Immunol. 2019;19(11):688-701.24. Vieyra-Garcia PA, Wolf
P. A deep dive into UV-based phototherapy: Mechanisms of action and
emerging molecular targets in inflammation and cancer. Pharmacol
Ther. 2021;222:107784.25. Chen W, Jin W, Hardegen N, et al. Conversion
of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by
TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875-1886.26. Xu L, Kitani A, Strober W. Molecular
mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal
Immunol. 2010;3(3):230-238.27. Akamatsu M, Mikami N, Ohkura N, et al.
Conversion of antigen-specific effector/memory T cells into
Foxp3-expressing T(reg) cells by inhibition of CDK8/19. Sci
Immunol. 2019;4(40).28. Turner M, Mee PJ, Walters AE, et al. A
requirement for the Rho-family GTP exchange factor Vav in positive and
negative selection of thymocytes. Immunity. 1997;7(4):451-460.29.
Tybulewicz VL, Ardouin L, Prisco A, Reynolds LF. Vav1: a key signal
transducer downstream of the TCR. Immunol Rev. 2003;192:42-52.30.
Korn T, Fischer KD, Girkontaite I, Kollner G, Toyka K, Jung S.
Vav1-deficient mice are resistant to MOG-induced experimental autoimmune
encephalomyelitis due to impaired antigen priming. J
Neuroimmunol. 2003;139(1-2):17-26.31. Xu T, Stewart KM, Wang X, et al.
Metabolic control of T(H)17 and induced T(reg) cell balance by an
epigenetic mechanism. Nature. 2017;548(7666):228-233.32. Aso K,
Kono M, Kanda M, et al. Itaconate ameliorates autoimmunity by modulating
T cell imbalance via metabolic and epigenetic reprogramming. Nat
Commun. 2023;14(1):984.33. Jordens I, Marsman M, Kuijl C, Neefjes J.
Rab proteins, connecting transport and vesicle fusion. Traffic. 2005;6(12):1070-1077.34. Grosshans BL, Ortiz D, Novick P. Rabs and their
effectors: achieving specificity in membrane traffic. Proc Natl
Acad Sci U S A. 2006;103(32):11821-11827.35. Yang CW, Hojer CD, Zhou M,
et al. Regulation of T Cell Receptor Signaling by DENND1B in TH2 Cells
and Allergic Disease. Cell. 2016;164(1-2):141-155.36. Oliveira
VG, Caridade M, Paiva RS, Demengeot J, Graca L. Sub-optimal CD4+ T-cell
activation triggers autonomous TGF-beta-dependent conversion to Foxp3+
regulatory T cells. Eur J Immunol. 2011;41(5):1249-1255.37. Lu
CH, Wu CJ, Chan CC, et al. DNA Methyltransferase Inhibitor Promotes
Human CD4(+)CD25(h)FOXP3(+) Regulatory T Lymphocyte Induction under
Suboptimal TCR Stimulation. Front Immunol. 2016;7:488.38. Li MO,
Rudensky AY. T cell receptor signalling in the control of regulatory T
cell differentiation and function. Nat Rev Immunol. 2016;16(4):220-233.39. Serr I, Furst RW, Achenbach P, et al. Type 1
diabetes vaccine candidates promote human Foxp3(+)Treg induction in
humanized mice. Nat Commun. 2016;7:10991.40. Nussbaum L, Chen YL,
Ogg GS. Role of regulatory T cells in psoriasis pathogenesis and
treatment. Br J Dermatol. 2021;184(1):14-24.41. Kim J, Moreno A,
Krueger JG. The imbalance between Type 17 T-cells and regulatory immune
cell subsets in psoriasis vulgaris. Front Immunol. 2022;13:1005115.42. Lee BH, Bang YJ, Lim SH, et al. High-dimensional
profiling of regulatory T cells in psoriasis reveals an impaired
skin-trafficking property. EBioMedicine. 2024;100:104985.